Hospitals' dialysis plan is under new scrutiny
For 400,000 people across the country with failed kidneys, dialysis care is a matter of life and death. It is also a lucrative business, in part because Medicare pays for such treatment regardless of age. But as for-profit clinics and chains have grown to control about 85 percent of the dialysis market over the last decade, researchers have documented starkly higher mortality rates in centers owned by for-profits compared with nonprofits. Now the New York State Public Health and Health Planning Council is set to vote Thursday on a deal to turn over dialysis at four of New York City's public hospitals to a for-profit franchise called Big Apple Dialysis despite government data showing the company's centers did not perform as well as the hospitals themselves.
- Few Winners Among MSSP Participants
- Technology Lights Up Health Innovation Forum
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Data Points to Boom in Private HIX
- EHR Systems 'Immature, Costly,' AMA Says
- NCQA Releases Annual Health Plan Rankings
- How much does that x-ray cost? You can find out in NH
- When a hospital closes
- Malnourishment 'Epidemic' Plagues Hospitals? Really?
- Interstate Medical Licensure Effort Advances